{"title":"露西系列:制度阴影下的自由剥夺","authors":"R. Reed-Berendt","doi":"10.1093/medlaw/fwac029","DOIUrl":null,"url":null,"abstract":"people’s autonomy and privacy, for equality, and for public health.’ Following the publication of this book, the FDA has since removed the in-person dispensing requirement which allowed the pills to be provided by mail in thirty-one states, thereby allowing pregnant persons to access TEMA services for the first time in the USA. However, this access may be under threat following the revocation of the constitutional right to abortion when Roe v Wade was overturned in June 2022. Examining the trajectory of TEMA access—or lack thereof—within these jurisdictions, the authors clearly identify that the nature of abortion policy in the UK and USA is driven by politics rather than by medical evidence. As such, this trend has created socio-legal barriers to accessing TEMA services in these jurisdictions even during and in the wake of the global COVID-19 pandemic restrictions. As a clear example of this, the authors highlight that the home use of misoprostol has long been available for the treatment of spontaneous miscarriage in the UK, and yet prior to 2018 this medication could only be provided under medical supervision for induced miscarriage. As the authors indicate, this rule was surely not based on clinical evidence but was more likely to be politically motivated. The specificity of this topic and the level of technical detail included within the book preclude it from being light reading material for a reader who does not have a direct interest in abortion access. Nevertheless, this is an essential read for those—especially academics, medical professionals, and policymakers—seeking a comprehensive understanding of the benefits of TEMA, the current access to these services in the UK and USA, and how access may be expanded by displacing legal and practical barriers in these jurisdictions.","PeriodicalId":49146,"journal":{"name":"Medical Law Review","volume":"30 1","pages":"757 - 762"},"PeriodicalIF":1.8000,"publicationDate":"2022-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Lucy Series, Deprivation of Liberty in the Shadows of the Institution\",\"authors\":\"R. Reed-Berendt\",\"doi\":\"10.1093/medlaw/fwac029\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"people’s autonomy and privacy, for equality, and for public health.’ Following the publication of this book, the FDA has since removed the in-person dispensing requirement which allowed the pills to be provided by mail in thirty-one states, thereby allowing pregnant persons to access TEMA services for the first time in the USA. However, this access may be under threat following the revocation of the constitutional right to abortion when Roe v Wade was overturned in June 2022. Examining the trajectory of TEMA access—or lack thereof—within these jurisdictions, the authors clearly identify that the nature of abortion policy in the UK and USA is driven by politics rather than by medical evidence. As such, this trend has created socio-legal barriers to accessing TEMA services in these jurisdictions even during and in the wake of the global COVID-19 pandemic restrictions. As a clear example of this, the authors highlight that the home use of misoprostol has long been available for the treatment of spontaneous miscarriage in the UK, and yet prior to 2018 this medication could only be provided under medical supervision for induced miscarriage. As the authors indicate, this rule was surely not based on clinical evidence but was more likely to be politically motivated. The specificity of this topic and the level of technical detail included within the book preclude it from being light reading material for a reader who does not have a direct interest in abortion access. Nevertheless, this is an essential read for those—especially academics, medical professionals, and policymakers—seeking a comprehensive understanding of the benefits of TEMA, the current access to these services in the UK and USA, and how access may be expanded by displacing legal and practical barriers in these jurisdictions.\",\"PeriodicalId\":49146,\"journal\":{\"name\":\"Medical Law Review\",\"volume\":\"30 1\",\"pages\":\"757 - 762\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2022-08-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Law Review\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/medlaw/fwac029\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"LAW\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Law Review","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/medlaw/fwac029","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"LAW","Score":null,"Total":0}
Lucy Series, Deprivation of Liberty in the Shadows of the Institution
people’s autonomy and privacy, for equality, and for public health.’ Following the publication of this book, the FDA has since removed the in-person dispensing requirement which allowed the pills to be provided by mail in thirty-one states, thereby allowing pregnant persons to access TEMA services for the first time in the USA. However, this access may be under threat following the revocation of the constitutional right to abortion when Roe v Wade was overturned in June 2022. Examining the trajectory of TEMA access—or lack thereof—within these jurisdictions, the authors clearly identify that the nature of abortion policy in the UK and USA is driven by politics rather than by medical evidence. As such, this trend has created socio-legal barriers to accessing TEMA services in these jurisdictions even during and in the wake of the global COVID-19 pandemic restrictions. As a clear example of this, the authors highlight that the home use of misoprostol has long been available for the treatment of spontaneous miscarriage in the UK, and yet prior to 2018 this medication could only be provided under medical supervision for induced miscarriage. As the authors indicate, this rule was surely not based on clinical evidence but was more likely to be politically motivated. The specificity of this topic and the level of technical detail included within the book preclude it from being light reading material for a reader who does not have a direct interest in abortion access. Nevertheless, this is an essential read for those—especially academics, medical professionals, and policymakers—seeking a comprehensive understanding of the benefits of TEMA, the current access to these services in the UK and USA, and how access may be expanded by displacing legal and practical barriers in these jurisdictions.
期刊介绍:
The Medical Law Review is established as an authoritative source of reference for academics, lawyers, legal and medical practitioners, law students, and anyone interested in healthcare and the law.
The journal presents articles of international interest which provide thorough analyses and comment on the wide range of topical issues that are fundamental to this expanding area of law. In addition, commentary sections provide in depth explorations of topical aspects of the field.